Blank, Michael, 		Mandel, Mathilda, 		Dror, Naama, 		Solomon, Arieh, 		Barlyia, Tilda, AND 		Lavie, Dr. Gad.
" Hypericin targets multiple signaling mediators in cancer cells generating unique, diverse anti-tumoral, anti-metastatic, and anti-angiogenic activities with evidence for clinical applicability" <em>Medical Research Archives</em> [Online], Volume 5 Number 3 (15 March 2017)